Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology

Recruiting now

Conditions studied: Ovarian Cancer

In brief

The findings from this study have the potential to serve as a foundation for evaluating the current practices related to surgical procedures, systemic therapies, hyperthermic intraperitoneal chemotherapy, and referrals to geneticists for OC patients. By identifying the strengths and weaknesses of the existing care, this project intends to generate valuable insights that can lead to the implementation of quality parameters for the treatment of ovarian cancer in the country.

Key facts

Study ID

NCT07167433

Run by

AstraZeneca

People needed

250

Starts

2025-09-19

Expected to finish

2027-06-30

Last updated by the study team

2026-08-04

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients ≥18 years old;
• Newly diagnosed ovarian cancer stages IA to IVB, or persistent or recurrent disease from January 2021;
• Irrespective of histology

You may not qualify if…

• Borderline tumors;
• Pregnancy;
• Synchronous tumor or second primary in the last 5 years (except thyroid cancer and non-melanoma skin cancer);

Where it is running

• Research Site — Salvador/BA, Brazil (enrolling)
• Research Site — Belo Horizonte/MG, Brazil (enrolling)
• Research Site — Bras lia/DF, Brazil (enrolling)
• Research Site — Curitiba/PR, Brazil (enrolling)
• Research Site — Goi nia/GO, Brazil (enrolling)
• Research Site — Joao Pessoa/PB, Brazil (enrolling)
• Research Site — Natal/RN, Brazil (enrolling)
• Research Site — Porto Alegre/RS, Brazil (enrolling)
• Research Site — Barretos/SP, Brazil (enrolling)
• Research Site — Recife/PE, Brazil (enrolling)
• Research Site — Rio Branco/AC, Brazil (enrolling)
• Research Site — Rio de Janeiro/RJ, Brazil (enrolling)
• Research Site — S O Jose Dos Campos/SP, Brazil (enrolling)
• Research Site — S O Paulo/SP, Brazil (enrolling)
• Research Site — Porto Alegre/RS, Brazil

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.